{"ticker": {"uuid": "62f9bf27-60c8-4211-bad2-6ec93acad04c", "symbol": "CODX", "name": "Co-Diagnostics, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Why Did CODX Stock Nearly Double In Value Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNMC14UUpQWkNGelFOUVo4LVBNWWQwbkxudG9VYXZxcTlIWVItX1F4UVFQS0tEYUxzZzZGblBTN2JnSnhVV0RrSjcyZ1BDcFF5X09DUS1hbTFwYVVFSnNLY1gtaTFuaEpGak9SNUdadDEtMUxqclp2WG4tZ2FLSHNfT05FTENaR1N5RFNSZzdEeTVTa0ZmRDRsSUZfbUhDRldmVXM5WA?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-11T14:31:13+00:00", "published_display": "11 Jul 2026 14:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CODX Stock Price, Quote & Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTFB5WEpMZDdXVXRKWS1WM0YxRmFzS1J4c2VucHhET1VmNHlSWGJGM3FubnZPb0paeHJKQzJXTXNtX3RobkJheFNlNFlDRWFvXzc3OHNMU0VhNlk5RGhrbzVR?oc=5", "source_name": "ChartMill", "published_at": "2026-07-10T07:00:00+00:00", "published_display": "10 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-diagnostics(CODX) Stock Options Chain | Quotes & News", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moomoo", "published_at": "2026-07-07T02:36:21+00:00", "published_display": "07 Jul 2026 02:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CODX Stock Explodes Over 630% In Six Sessions \u2013 Retail Traders Bet The Rally Isn\u2019t Over Yet", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNTGw2UkRJNlhjWkN2bFZVZkFFZHpYMWVibUJuN3F2Q3pvTGdTVGVUS2dkYzlnV1p1NUJXN0hkN0dBdjFYcU5hTWY2S2l4VnZrRFNkU2tKNHBTVUxNRWJ3VHVRZXl2SkZ2bzZFM3dpS211R0dvem5OYng3ZV9Ua2RSUld5V3JXSDd2VzYyM3JpVEdrYmQtUVlEZmM2ZWRlaEU?oc=5", "source_name": "Stocktwits", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai", "summary": "Co-Diagnostics, Inc. announced its participation in the World Health Expo Labs Dubai from February 10-13, 2026, where it will showcase its Co-Dx\u2122 PCR platform. This exhibition follows the formation of its joint venture, CoMira Diagnostics, aimed at localizing manufacturing and di", "url": "https://www.morningstar.com/news/pr-newswire/20260209la83318/co-diagnostics-to-showcase-pcr-platform-at-world-health-expo-labs-dubai", "source_name": "Morningstar", "published_at": "2026-02-09T14:00:00", "published_display": "09 Feb 2026 14:00", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform", "summary": "Co-Diagnostics, Inc.'s joint venture, CoSara Diagnostics Pvt. Ltd., has achieved ISO 13485:2016 certification for its manufacturing facility in Vadodara, India. This certification is a crucial step for securing regulatory clearance for their upcoming PCR platform and other medica", "url": "https://www.prnewswire.com/news-releases/co-diagnostics-jv-cosara-receives-iso-13485-certification-in-preparation-for-manufacturing-upcoming-pcr-platform-302678710.html", "source_name": "PR Newswire", "published_at": "2026-02-04T09:00:00", "published_display": "04 Feb 2026 09:00", "sentiment": "positive", "sentiment_pct": 73, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics Shares Transition to Over-the-Counter Trading", "summary": "Co-Diagnostics Inc. (CODX) has moved from the Nasdaq Capital Market to over-the-counter trading due to its inability to maintain the minimum share price requirement. Despite a 1-for-30 reverse stock split, the company failed to sustain a $1.00 closing bid price. This delisting fo", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/co-diagnostics-shares-transition-to-over-the-counter-trading/68496611", "source_name": "AD HOC NEWS", "published_at": "2026-01-18T06:28:03", "published_display": "18 Jan 2026 06:28", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CODX Stock Price, Forecast & Analysis | CO-DIAGNOSTICS INC (NASDAQ:CODX)", "summary": "This article provides an in-depth analysis of CO-DIAGNOSTICS INC (CODX) stock, including its current price, historical performance, and key statistics. It also features technical and fundamental analysis, analyst ratings, and financial highlights, concluding with a company profil", "url": "https://www.chartmill.com/stock/quote/CODX/profile", "source_name": "Chartmill", "published_at": "2026-01-15T04:57:28", "published_display": "15 Jan 2026 04:57", "sentiment": "negative", "sentiment_pct": 19, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics Faces Nasdaq Delisting After Bid Price Noncompliance", "summary": "Co-Diagnostics (CODX) is facing delisting from the Nasdaq Capital Market due to non-compliance with the minimum $1.00 bid price requirement. Trading in its securities is suspended from Nasdaq as of January 14, 2026, and will move to the OTC Market. Despite a recent reverse stock ", "url": "https://www.theglobeandmail.com/investing/markets/stocks/CODX-Q/pressreleases/37045162/co-diagnostics-faces-nasdaq-delisting-after-bid-price-noncompliance/", "source_name": "The Globe and Mail", "published_at": "2026-01-14T21:57:29", "published_display": "14 Jan 2026 21:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics Received Notice of Delisting", "summary": "Co-Diagnostics (CODX) received a delisting notice from Nasdaq due to noncompliance with the $1.00 minimum bid price rule. Trading on The Nasdaq Capital Market will be suspended on January 14, 2026, and the stock is expected to move to the OTC Pink Limited Information tier. The co", "url": "https://www.tradingview.com/news/tradingview:d5bd5ff71d473:0-co-diagnostics-received-notice-of-delisting/", "source_name": "TradingView \u2014 Track All Markets", "published_at": "2026-01-13T17:27:54", "published_display": "13 Jan 2026 17:27", "sentiment": "negative", "sentiment_pct": 13, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market", "summary": "Co-Diagnostics (NASDAQ: CODX) is facing delisting from the Nasdaq Capital Market due to its failure to meet the minimum bid price requirement. The company's securities will be suspended from Nasdaq trading and will move to the Pink Limited Information tier of the OTC Market. Desp", "url": "https://www.investing.com/news/sec-filings/codiagnostics-to-be-delisted-from-nasdaq-trading-to-move-to-otc-market-93CH-4445374", "source_name": "Investing.com", "published_at": "2026-01-13T17:27:54", "published_display": "13 Jan 2026 17:27", "sentiment": "negative", "sentiment_pct": 8, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics announces 1-for-30 reverse stock split By Investing.com", "summary": "Co-Diagnostics, Inc. (NASDAQ:CODX) will effect a 1-for-30 reverse stock split on January 2, 2026, to meet Nasdaq's minimum bid price requirement. The company's stock has plummeted 69.44% year-to-date, and it reported significant revenue decline in Q3 2025. Despite financial chall", "url": "https://za.investing.com/news/company-news/codiagnostics-announces-1for30-reverse-stock-split-93CH-4043049", "source_name": "Investing.com South Africa", "published_at": "2026-01-12T17:58:20", "published_display": "12 Jan 2026 17:58", "sentiment": "negative", "sentiment_pct": 28, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships", "summary": "Co-Diagnostics, Inc. announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd., is expanding its distributor base in India by participating in regional conferences. CoSara introduced its SARAGENE\u00ae diagnostic products and the upcoming Co-Dx\u2122 PCR platform to new custome", "url": "https://www.prnewswire.com/news-releases/co-diagnostics-jv-cosara-participates-in-regional-conferences-to-grow-and-strengthen-distributor-relationships-302658374.html", "source_name": "PR Newswire", "published_at": "2026-01-12T13:58:20", "published_display": "12 Jan 2026 13:58", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics Approves Reverse Stock Split to Maintain Listing", "summary": "Co-Diagnostics (CODX) has approved a 1-for-30 reverse stock split, effective January 2, 2026, to regain compliance with Nasdaq's minimum bid price requirement. This move is aimed at preserving the company's listing and access to public capital markets. While analysts have a \"Hold", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/36841610/co-diagnostics-approves-reverse-stock-split-to-maintain-listing/", "source_name": "The Globe and Mail", "published_at": "2025-12-31T15:09:02", "published_display": "31 Dec 2025 15:09", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics announces 1-for-30 reverse stock split", "summary": "Co-Diagnostics (CODX) has announced a 1-for-30 reverse stock split of its common stock, effective January 2, 2026, to regain compliance with Nasdaq's minimum bid price requirement. The company's stock will continue trading on The Nasdaq Capital Market under the symbol \"CODX\" on a", "url": "https://finance.yahoo.com/news/co-diagnostics-announces-1-30-141033234.html", "source_name": "Market source", "published_at": "2025-12-31T14:09:02", "published_display": "31 Dec 2025 14:09", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics (CODX) Announces 1-for-30 Reverse Stock Split", "summary": "Co-Diagnostics (CODX) is implementing a 1-for-30 reverse stock split on January 2, 2026, to meet Nasdaq's minimum bid price requirement. The company, operating in molecular diagnostics, faces significant financial challenges, including negative margins and declining revenue. Desp", "url": "https://www.gurufocus.com/news/4089885/codiagnostics-codx-announces-1for30-reverse-stock-split?mobile=true", "source_name": "GuruFocus", "published_at": "2025-12-30T19:09:37", "published_display": "30 Dec 2025 19:09", "sentiment": "negative", "sentiment_pct": 10, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CODX Stock Plunges To All-Time Lows On 1-for-30 Reverse Stock Split Approval", "summary": "Co-Diagnostics Inc. (CODX) shares plunged 20% to an all-time low following the announcement of a 1-for-30 reverse stock split. This move aims to regain compliance with Nasdaq's minimum bid price rule. The reverse split will become effective on January 2, resulting in approximatel", "url": "https://stocktwits.com/news-articles/markets/equity/codx-stock-plunges-to-all-time-lows-on-1-for-30-reverse-stock-split-approval/cL7I3lLREy5", "source_name": "Stocktwits", "published_at": "2025-12-30T16:09:37", "published_display": "30 Dec 2025 16:09", "sentiment": "negative", "sentiment_pct": 14, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics stock plunges after announcing 1-for-30 reverse split", "summary": "Co-Diagnostics Inc. (NASDAQ:CODX) stock plummeted 13.8% after the company announced a 1-for-30 reverse stock split. This move is intended to bring Co-Diagnostics into compliance with Nasdaq's $1.00 minimum bid price requirement. The reverse split will take effect on January 2, 20", "url": "https://www.investing.com/news/stock-market-news/codiagnostics-stock-plunges-after-announcing-1for30-reverse-split-93CH-4425515", "source_name": "Investing.com", "published_at": "2025-12-30T15:09:37", "published_display": "30 Dec 2025 15:09", "sentiment": "negative", "sentiment_pct": 26, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech Co-Diagnostics shrinks share count 30-to-1 to stay on Nasdaq", "summary": "Co-Diagnostics (CODX) has announced a 1-for-30 reverse stock split, effective January 2, 2026, to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split will consolidate outstanding shares, adjust equity incentive plans, and round up fractional shares. The", "url": "https://www.stocktitan.net/news/CODX/co-diagnostics-announces-reverse-stock-yy1gh7lvbbcj.html", "source_name": "Stock Titan", "published_at": "2025-12-30T14:09:37", "published_display": "30 Dec 2025 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics Announces Reverse Stock Split", "summary": "Co-Diagnostics, Inc. has announced a 1-for-30 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement. The split will be effective January 2, 2026, with trading on a split-adjusted basis beginning the same day. Stockholders approved a reverse split ra", "url": "https://www.prnewswire.com/news-releases/co-diagnostics-announces-reverse-stock-split-302650274.html", "source_name": "PR Newswire", "published_at": "2025-12-30T14:09:37", "published_display": "30 Dec 2025 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Why Did CODX Stock Nearly Double In Value Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNMC14UUpQWkNGelFOUVo4LVBNWWQwbkxudG9VYXZxcTlIWVItX1F4UVFQS0tEYUxzZzZGblBTN2JnSnhVV0RrSjcyZ1BDcFF5X09DUS1hbTFwYVVFSnNLY1gtaTFuaEpGak9SNUdadDEtMUxqclp2WG4tZ2FLSHNfT05FTENaR1N5RFNSZzdEeTVTa0ZmRDRsSUZfbUhDRldmVXM5WA?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-11T14:31:13+00:00", "published_display": "11 Jul 2026 14:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CODX Stock Price, Quote & Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTFB5WEpMZDdXVXRKWS1WM0YxRmFzS1J4c2VucHhET1VmNHlSWGJGM3FubnZPb0paeHJKQzJXTXNtX3RobkJheFNlNFlDRWFvXzc3OHNMU0VhNlk5RGhrbzVR?oc=5", "source_name": "ChartMill", "published_at": "2026-07-10T07:00:00+00:00", "published_display": "10 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-diagnostics(CODX) Stock Options Chain | Quotes & News", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moomoo", "published_at": "2026-07-07T02:36:21+00:00", "published_display": "07 Jul 2026 02:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CODX Stock Explodes Over 630% In Six Sessions \u2013 Retail Traders Bet The Rally Isn\u2019t Over Yet", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNTGw2UkRJNlhjWkN2bFZVZkFFZHpYMWVibUJuN3F2Q3pvTGdTVGVUS2dkYzlnV1p1NUJXN0hkN0dBdjFYcU5hTWY2S2l4VnZrRFNkU2tKNHBTVUxNRWJ3VHVRZXl2SkZ2bzZFM3dpS211R0dvem5OYng3ZV9Ua2RSUld5V3JXSDd2VzYyM3JpVEdrYmQtUVlEZmM2ZWRlaEU?oc=5", "source_name": "Stocktwits", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai", "summary": "Co-Diagnostics, Inc. announced its participation in the World Health Expo Labs Dubai from February 10-13, 2026, where it will showcase its Co-Dx\u2122 PCR platform. This exhibition follows the formation of its joint venture, CoMira Diagnostics, aimed at localizing manufacturing and di", "url": "https://www.morningstar.com/news/pr-newswire/20260209la83318/co-diagnostics-to-showcase-pcr-platform-at-world-health-expo-labs-dubai", "source_name": "Morningstar", "published_at": "2026-02-09T14:00:00", "published_display": "09 Feb 2026 14:00", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform", "summary": "Co-Diagnostics, Inc.'s joint venture, CoSara Diagnostics Pvt. Ltd., has achieved ISO 13485:2016 certification for its manufacturing facility in Vadodara, India. This certification is a crucial step for securing regulatory clearance for their upcoming PCR platform and other medica", "url": "https://www.prnewswire.com/news-releases/co-diagnostics-jv-cosara-receives-iso-13485-certification-in-preparation-for-manufacturing-upcoming-pcr-platform-302678710.html", "source_name": "PR Newswire", "published_at": "2026-02-04T09:00:00", "published_display": "04 Feb 2026 09:00", "sentiment": "positive", "sentiment_pct": 73, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics Shares Transition to Over-the-Counter Trading", "summary": "Co-Diagnostics Inc. (CODX) has moved from the Nasdaq Capital Market to over-the-counter trading due to its inability to maintain the minimum share price requirement. Despite a 1-for-30 reverse stock split, the company failed to sustain a $1.00 closing bid price. This delisting fo", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/co-diagnostics-shares-transition-to-over-the-counter-trading/68496611", "source_name": "AD HOC NEWS", "published_at": "2026-01-18T06:28:03", "published_display": "18 Jan 2026 06:28", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CODX Stock Price, Forecast & Analysis | CO-DIAGNOSTICS INC (NASDAQ:CODX)", "summary": "This article provides an in-depth analysis of CO-DIAGNOSTICS INC (CODX) stock, including its current price, historical performance, and key statistics. It also features technical and fundamental analysis, analyst ratings, and financial highlights, concluding with a company profil", "url": "https://www.chartmill.com/stock/quote/CODX/profile", "source_name": "Chartmill", "published_at": "2026-01-15T04:57:28", "published_display": "15 Jan 2026 04:57", "sentiment": "negative", "sentiment_pct": 19, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics Faces Nasdaq Delisting After Bid Price Noncompliance", "summary": "Co-Diagnostics (CODX) is facing delisting from the Nasdaq Capital Market due to non-compliance with the minimum $1.00 bid price requirement. Trading in its securities is suspended from Nasdaq as of January 14, 2026, and will move to the OTC Market. Despite a recent reverse stock ", "url": "https://www.theglobeandmail.com/investing/markets/stocks/CODX-Q/pressreleases/37045162/co-diagnostics-faces-nasdaq-delisting-after-bid-price-noncompliance/", "source_name": "The Globe and Mail", "published_at": "2026-01-14T21:57:29", "published_display": "14 Jan 2026 21:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics Received Notice of Delisting", "summary": "Co-Diagnostics (CODX) received a delisting notice from Nasdaq due to noncompliance with the $1.00 minimum bid price rule. Trading on The Nasdaq Capital Market will be suspended on January 14, 2026, and the stock is expected to move to the OTC Pink Limited Information tier. The co", "url": "https://www.tradingview.com/news/tradingview:d5bd5ff71d473:0-co-diagnostics-received-notice-of-delisting/", "source_name": "TradingView \u2014 Track All Markets", "published_at": "2026-01-13T17:27:54", "published_display": "13 Jan 2026 17:27", "sentiment": "negative", "sentiment_pct": 13, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market", "summary": "Co-Diagnostics (NASDAQ: CODX) is facing delisting from the Nasdaq Capital Market due to its failure to meet the minimum bid price requirement. The company's securities will be suspended from Nasdaq trading and will move to the Pink Limited Information tier of the OTC Market. Desp", "url": "https://www.investing.com/news/sec-filings/codiagnostics-to-be-delisted-from-nasdaq-trading-to-move-to-otc-market-93CH-4445374", "source_name": "Investing.com", "published_at": "2026-01-13T17:27:54", "published_display": "13 Jan 2026 17:27", "sentiment": "negative", "sentiment_pct": 8, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics announces 1-for-30 reverse stock split By Investing.com", "summary": "Co-Diagnostics, Inc. (NASDAQ:CODX) will effect a 1-for-30 reverse stock split on January 2, 2026, to meet Nasdaq's minimum bid price requirement. The company's stock has plummeted 69.44% year-to-date, and it reported significant revenue decline in Q3 2025. Despite financial chall", "url": "https://za.investing.com/news/company-news/codiagnostics-announces-1for30-reverse-stock-split-93CH-4043049", "source_name": "Investing.com South Africa", "published_at": "2026-01-12T17:58:20", "published_display": "12 Jan 2026 17:58", "sentiment": "negative", "sentiment_pct": 28, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships", "summary": "Co-Diagnostics, Inc. announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd., is expanding its distributor base in India by participating in regional conferences. CoSara introduced its SARAGENE\u00ae diagnostic products and the upcoming Co-Dx\u2122 PCR platform to new custome", "url": "https://www.prnewswire.com/news-releases/co-diagnostics-jv-cosara-participates-in-regional-conferences-to-grow-and-strengthen-distributor-relationships-302658374.html", "source_name": "PR Newswire", "published_at": "2026-01-12T13:58:20", "published_display": "12 Jan 2026 13:58", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics Approves Reverse Stock Split to Maintain Listing", "summary": "Co-Diagnostics (CODX) has approved a 1-for-30 reverse stock split, effective January 2, 2026, to regain compliance with Nasdaq's minimum bid price requirement. This move is aimed at preserving the company's listing and access to public capital markets. While analysts have a \"Hold", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/36841610/co-diagnostics-approves-reverse-stock-split-to-maintain-listing/", "source_name": "The Globe and Mail", "published_at": "2025-12-31T15:09:02", "published_display": "31 Dec 2025 15:09", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics announces 1-for-30 reverse stock split", "summary": "Co-Diagnostics (CODX) has announced a 1-for-30 reverse stock split of its common stock, effective January 2, 2026, to regain compliance with Nasdaq's minimum bid price requirement. The company's stock will continue trading on The Nasdaq Capital Market under the symbol \"CODX\" on a", "url": "https://finance.yahoo.com/news/co-diagnostics-announces-1-30-141033234.html", "source_name": "Market source", "published_at": "2025-12-31T14:09:02", "published_display": "31 Dec 2025 14:09", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics (CODX) Announces 1-for-30 Reverse Stock Split", "summary": "Co-Diagnostics (CODX) is implementing a 1-for-30 reverse stock split on January 2, 2026, to meet Nasdaq's minimum bid price requirement. The company, operating in molecular diagnostics, faces significant financial challenges, including negative margins and declining revenue. Desp", "url": "https://www.gurufocus.com/news/4089885/codiagnostics-codx-announces-1for30-reverse-stock-split?mobile=true", "source_name": "GuruFocus", "published_at": "2025-12-30T19:09:37", "published_display": "30 Dec 2025 19:09", "sentiment": "negative", "sentiment_pct": 10, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CODX Stock Plunges To All-Time Lows On 1-for-30 Reverse Stock Split Approval", "summary": "Co-Diagnostics Inc. (CODX) shares plunged 20% to an all-time low following the announcement of a 1-for-30 reverse stock split. This move aims to regain compliance with Nasdaq's minimum bid price rule. The reverse split will become effective on January 2, resulting in approximatel", "url": "https://stocktwits.com/news-articles/markets/equity/codx-stock-plunges-to-all-time-lows-on-1-for-30-reverse-stock-split-approval/cL7I3lLREy5", "source_name": "Stocktwits", "published_at": "2025-12-30T16:09:37", "published_display": "30 Dec 2025 16:09", "sentiment": "negative", "sentiment_pct": 14, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics stock plunges after announcing 1-for-30 reverse split", "summary": "Co-Diagnostics Inc. (NASDAQ:CODX) stock plummeted 13.8% after the company announced a 1-for-30 reverse stock split. This move is intended to bring Co-Diagnostics into compliance with Nasdaq's $1.00 minimum bid price requirement. The reverse split will take effect on January 2, 20", "url": "https://www.investing.com/news/stock-market-news/codiagnostics-stock-plunges-after-announcing-1for30-reverse-split-93CH-4425515", "source_name": "Investing.com", "published_at": "2025-12-30T15:09:37", "published_display": "30 Dec 2025 15:09", "sentiment": "negative", "sentiment_pct": 26, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech Co-Diagnostics shrinks share count 30-to-1 to stay on Nasdaq", "summary": "Co-Diagnostics (CODX) has announced a 1-for-30 reverse stock split, effective January 2, 2026, to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split will consolidate outstanding shares, adjust equity incentive plans, and round up fractional shares. The", "url": "https://www.stocktitan.net/news/CODX/co-diagnostics-announces-reverse-stock-yy1gh7lvbbcj.html", "source_name": "Stock Titan", "published_at": "2025-12-30T14:09:37", "published_display": "30 Dec 2025 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Co-Diagnostics Announces Reverse Stock Split", "summary": "Co-Diagnostics, Inc. has announced a 1-for-30 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement. The split will be effective January 2, 2026, with trading on a split-adjusted basis beginning the same day. Stockholders approved a reverse split ra", "url": "https://www.prnewswire.com/news-releases/co-diagnostics-announces-reverse-stock-split-302650274.html", "source_name": "PR Newswire", "published_at": "2025-12-30T14:09:37", "published_display": "30 Dec 2025 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 85, "total_relevant": 36, "sentiment_summary": {"positive": 4, "negative": 10, "neutral": 22, "score": 43, "total": 36, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 10.05, "count": 17}, {"event": "earnings", "label": "Earnings", "weight": 7.99, "count": 16}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 10}, "market_context": {"has_market_context": true, "latest_close": 2.61, "latest_week": "2026-07-10", "one_week_move": -12.7, "four_week_move": -39.2, "twelve_week_move": 67.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.447927, "market_dynamics_buy_signal": false, "relative_strength": -65.142222, "fair_value_gap": -88.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.9925, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-12.7% over one week, -39.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 66, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 10}, {"label": "Stocktwits", "count": 3}, {"label": "StockStory", "count": 3}, {"label": "PR Newswire", "count": 3}, {"label": "Barron's", "count": 2}, {"label": "The Globe and Mail", "count": 2}, {"label": "Investing.com", "count": 2}, {"label": "ChartMill", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 25}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 17}, {"label": "Earnings", "count": 16}, {"label": "Regulatory and legal", "count": 2}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "43/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "25", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-12.7% over one week, -39.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Why Did CODX Stock Nearly Double In Value Today?"}], "updated_at": "2026-07-16T12:56:54.634090+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}